|
Pronunciation |
|
(LAK
tyoo
lose) |

|
|
U.S. Brand
Names |
|
Cephulac®; Cholac®;
Chronulac®; Constilac®; Constulose®;
Duphalac®; Enulose®; Evalose®; Heptalac®;
Lactulose
PSE® |

|
|
Generic
Available |
|
Yes |

|
|
Pharmacological Index |
|
Ammonium Detoxicant; Laxative, Miscellaneous |

|
|
Use |
|
Adjunct in the prevention and treatment of portal-systemic encephalopathy
(PSE); treatment of chronic constipation |

|
|
Pregnancy Risk
Factor |
|
B |

|
|
Contraindications |
|
Patients with galactosemia and require a low galactose diet, hypersensitivity
to any component |

|
|
Warnings/Precautions |
|
Use with caution in patients with diabetes mellitus; monitor periodically for
electrolyte imbalance when lactulose is used >6 months or in patients
predisposed to electrolyte abnormalities (eg, elderly); patients receiving
lactulose and an oral anti-infective agent should be monitored for possible
inadequate response to lactulose |

|
|
Adverse
Reactions |
|
>10%: Gastrointestinal: Flatulence, diarrhea (excessive dose)
1% to 10%: Gastrointestinal: Abdominal discomfort, nausea, vomiting
|

|
|
Overdosage/Toxicology |
|
Symptoms of overdose include diarrhea, abdominal pain, hypochloremic
alkalosis, dehydration, hypotension, hypokalemia
Treatment includes supportive care |

|
|
Drug
Interactions |
|
Decreased effect: Oral neomycin, laxatives, antacids |

|
|
Stability |
|
Keep solution at room temperature to reduce viscosity; discard solution if
cloudy or very dark |

|
|
Mechanism of
Action |
|
The bacterial degradation of lactulose resulting in an acidic pH inhibits the
diffusion of NH3 into the blood by causing the conversion of
NH3 to NH4+; also enhances the diffusion of NH3
from the blood into the gut where conversion to NH4+ occurs; produces
an osmotic effect in the colon with resultant distention promoting
peristalsis |

|
|
Pharmacodynamics/Kinetics |
|
Absorption: Oral: Not absorbed appreciably following administration; this is
desirable since the intended site of action is within the colon
Metabolism: By colonic flora to lactic acid and acetic acid, requires colonic
flora for primary drug activation
Elimination: Primarily in feces and urine (~3%) |

|
|
Usual Dosage |
|
Diarrhea may indicate overdosage and responds to dose reduction
Infants: 2.5-10 mL/day divided 3-4 times/day; adjust dosage to produce 2-3
stools/day
Older Children: Daily dose of 40-90 mL divided 3-4 times/day; if initial dose
causes diarrhea, then reduce it immediately; adjust dosage to produce 2-3
stools/day
Constipation:
Children: 5 g/day (7.5 mL) after breakfast
Adults:
Acute PSE:
Oral: 20-30 g (30-45 mL) every 1-2 hours to induce rapid laxation; adjust
dosage daily to produce 2-3 soft stools; doses of 30-45 mL may be given hourly
to cause rapid laxation, then reduce to recommended dose; usual daily dose:
60-100 g (90-150 mL) daily
Rectal administration: 200 g (300 mL) diluted with 700 mL of H20
or NS; administer rectally via rectal balloon catheter and retain 30-60 minutes
every 4-6 hours
Constipation: Oral: 15-30 mL/day increased to 60 mL/day if necessary
|

|
|
Dietary
Considerations |
|
Contraindicated in patients on galactose-restricted diet; may be mixed with
fruit juice, milk, water, or citrus-flavored carbonated
beverages |

|
|
Monitoring
Parameters |
|
Blood pressure, standing/supine; serum potassium, bowel movement patterns,
fluid status, serum ammonia |

|
|
Mental Health: Effects
on Mental Status |
|
None reported |

|
|
Mental Health:
Effects on Psychiatric
Treatment |
|
None reported |

|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |

|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |

|
|
Patient
Information |
|
Not for long-term use. Take as directed, alone, or diluted with water, juice
or milk, or take with food. Laxative results may not occur for 24-48 hours; do
not take more often than recommended or for a longer time than recommended. Do
not use any other laxatives while taking lactulose. Increased fiber, fluids, and
exercise may help reduce constipation. Do not use if experiencing abdominal
pain, nausea, or vomiting. Diarrhea may indicate overdose. May cause flatulence,
belching, or abdominal cramping. Report persistent or severe diarrhea or
abdominal cramping. Breast-feeding precautions: Consult prescriber if
breast-feeding. |

|
|
Nursing
Implications |
|
Dilute lactulose in water, usually 60-120 mL, prior to administering through
a gastric or feeding tube |

|
|
Dosage Forms |
|
Syrup: 10 g/15 mL (15 mL, 30 mL, 237 mL, 473 mL, 946 mL, 1890
mL) |

|
|
References |
|
Lederle FA, Busch DL, Mattox KM, et al,
"Cost-Effective Treatment of Constipation in the Elderly: A Randomized Double-Blind Comparison of Sorbitol and Lactulose,"
Am J Med, 1990, 89(5):597-601.
|

|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|